![](/img/cover-not-exists.png)
The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma
Yamane, Brett H, Hank, Jacquelyn A, Albertini, Mark R, Sondel, Paul MVolume:
18
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543780903048911
Date:
July, 2009
File:
PDF, 708 KB
english, 2009